These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 8099745)

  • 1. Towards a synthetic malaria vaccine: cyclization of a peptide eliminates the production of parasite-unreactive antibody.
    Etlinger HM; Trzeciak A
    Philos Trans R Soc Lond B Biol Sci; 1993 Apr; 340(1291):69-72. PubMed ID: 8099745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunogenicity of a recombinant malaria vaccine candidate, domain I+II of AMA-1 ectodomain, from Indian P. falciparum alleles.
    Lalitha PV; Biswas S; Pillai CR; Saxena RK
    Vaccine; 2008 Aug; 26(35):4526-35. PubMed ID: 18590786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody responses to a synthetic peptide-based malaria vaccine candidate: influence of sequence variants of the peptide.
    Etlinger HM; Renia L; Matile H; Manneberg M; Mazier D; Trzeciak A; Gillessen D
    Eur J Immunol; 1991 Jun; 21(6):1505-11. PubMed ID: 2044658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of two long synthetic merozoite surface protein 2 peptides as malaria vaccine candidates.
    Flueck C; Frank G; Smith T; Jafarshad A; Nebie I; Sirima SB; Olugbile S; Alonso P; Tanner M; Druilhe P; Felger I; Corradin G
    Vaccine; 2009 May; 27(20):2653-61. PubMed ID: 19428875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New B cell epitopes in the Plasmodium falciparum malaria circumsporozoite protein.
    Stüber D; Bannwarth W; Pink JR; Meloen RH; Matile H
    Eur J Immunol; 1990 Apr; 20(4):819-24. PubMed ID: 1693336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment in mice of a synthetic peptide-based vaccine against the sporozoite stage of the human malaria parasite, P. falciparum.
    Etlinger HM; Heimer EP; Trzeciak A; Felix AM; Gillessen D
    Immunology; 1988 Jul; 64(3):551-8. PubMed ID: 3044983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The N-terminal domain of Plasmodium falciparum circumsporozoite protein represents a target of protective immunity.
    Bongfen SE; Ntsama PM; Offner S; Smith T; Felger I; Tanner M; Alonso P; Nebie I; Romero JF; Silvie O; Torgler R; Corradin G
    Vaccine; 2009 Jan; 27(2):328-35. PubMed ID: 18984024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunity to Plasmodium falciparum malaria sporozoites by somatic transgene immunization.
    Gerloni M; Baliou WR; Billetta R; Zanetti M
    Nat Biotechnol; 1997 Sep; 15(9):876-81. PubMed ID: 9306403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment in humans of a synthetic peptide-based vaccine against the sporozoite stage of the human malaria parasite, Plasmodium falciparum.
    Etlinger HM; Felix AM; Gillessen D; Heimer EP; Just M; Pink JR; Sinigaglia F; Stürchler D; Takacs B; Trzeciak A
    J Immunol; 1988 Jan; 140(2):626-33. PubMed ID: 3275719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The antibody response in mice to carrier-free synthetic polymers of Plasmodium falciparum circumsporozoite repetitive epitope is I-Ab-restricted: possible implications for malaria vaccines.
    Del Giudice G; Cooper JA; Merino J; Verdini AS; Pessi A; Togna AR; Engers HD; Corradin G; Lambert PH
    J Immunol; 1986 Nov; 137(9):2952-5. PubMed ID: 3531341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of antibodies against the Plasmodium falciparum p126 antigen in non-responder H-2b and partial-responder H-2d mice using synthetic peptides.
    Gilardeau Truffinet M; Bossus M; Camus D; Delplace P; Mazingue C; Diesis E; Tartar A; Moreau S; Gras-Masse H; Banic DM
    Pept Res; 1996; 9(2):61-70. PubMed ID: 8738980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthetic peptides from P. falciparum sexual stage 25-kDa protein induce antibodies that react with the native protein: the role of IL-2 and conformational structure on immunogenicity of Pfs25.
    Quakyi IA; Miller LH; Good MF; Ahlers JD; Isaacs SN; Nunberg JH; Houghten RA; Keister DB; Coligan JE; Moss B
    Pept Res; 1995; 8(6):335-44. PubMed ID: 8838417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protection against malaria by Plasmodium yoelii sporozoite surface protein 2 linear peptide induction of CD4+ T cell- and IFN-gamma-dependent elimination of infected hepatocytes.
    Wang R; Charoenvit Y; Corradin G; De La Vega P; Franke ED; Hoffman SL
    J Immunol; 1996 Nov; 157(9):4061-7. PubMed ID: 8892640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of cellular and humoral responses to recombinant protein and synthetic peptides of exon2 region of Plasmodium falciparum erythrocyte membrane protein1 (PfEMP1) among malaria patients from an endemic region.
    Das P; Grewal JS; Mahajan B; Chauhan VS
    Parasitol Int; 2007 Mar; 56(1):51-9. PubMed ID: 17258500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a conserved region of Plasmodium falciparum MSP3 targeted by biologically active antibodies to improve vaccine design.
    Singh S; Soe S; Mejia JP; Roussilhon C; Theisen M; Corradin G; Druilhe P
    J Infect Dis; 2004 Sep; 190(5):1010-8. PubMed ID: 15295710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IgG(4) Pf NPNA-1 a human anti-Plasmodium falciparum sporozoite monoclonal antibody cloned from a protected individual inhibits parasite invasion of hepatocytes.
    Chappel JA; Hollingdale MR; Kang AS
    Hum Antibodies; 2004; 13(3):91-6. PubMed ID: 15598989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody response profiles induced by Plasmodium falciparum glutamate-rich protein in naturally exposed individuals from a Brazilian area endemic for malaria.
    Pratt-Riccio LR; Lima-Junior JC; Carvalho LJ; Theisen M; Espíndola-Mendes EC; Santos F; Oliveira-Ferreira J; Goldberg AC; Daniel-Ribeiro CT; Banic DM
    Am J Trop Med Hyg; 2005 Dec; 73(6):1096-103. PubMed ID: 16354819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age-dependent systemic antibody responses and immunisation-associated changes in mice orally and nasally immunised with Lactococcus lactis expressing a malaria parasite protein.
    Moorthy SA; Yasawardena SG; Ramasamy R
    Vaccine; 2009 Aug; 27(36):4947-52. PubMed ID: 19545652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Use of synthetic carriers and adjuvants for increasing the immunogenicity of a synthetic peptide from the CS-protein of Plasmodium falciparum].
    Ivanov BB; Meshcheriakova EA; Andronova TM; Ivanov VT
    Bioorg Khim; 1991 Jun; 17(6):732-46. PubMed ID: 1723268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunization with recombinant duffy binding-like-gamma3 induces pan-reactive and adhesion-blocking antibodies against placental chondroitin sulfate A-binding Plasmodium falciparum parasites.
    Costa FT; Fusaï T; Parzy D; Sterkers Y; Torrentino M; Douki JB; Traoré B; Petres S; Scherf A; Gysin J
    J Infect Dis; 2003 Jul; 188(1):153-64. PubMed ID: 12825185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.